UK HealthCare is the health care system that is based on the campus of the University of Kentucky in Lexington, Kentucky. It consists of the university's hospitals, clinics, outreach locations, and patient care services along with UKs health profession colleges.

During the past decade, University of Kentucky Medical Center conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 63 clinical trials were completed, i.e. on average, 71.6% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 39 clinical trials were completed. i.e. 177.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kentucky Medical Center" #1 sponsor was "University of Kentucky" with 10 trials, followed by "Celgene" with 7 trials sponsored, "Baxalta now part of Shire" with 4 trials sponsored, "BioMarin Pharmaceutical" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 145 different institutions and companies that sponsored additional 116 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kentucky Medical Center" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 10 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 9 trials as a collaborator, "Medical University of South Carolina" with 5 trials as a collaborator, "University of Kentucky" with 4 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator. Other collaborators include 77 different institutions and companies that were collaborators in the rest 75 trials.

According to Clinical.Site data, the most researched conditions in "University of Kentucky Medical Center" are "HIV Infections" (10 trials), "Crohn's Disease" (8 trials), "Ulcerative Colitis" (7 trials), "Breast Cancer" (6 trials) and "Crohn Disease" (5 trials). Many other conditions were trialed in "University of Kentucky Medical Center" in a lesser frequency.

Most popular intervention types in "University of Kentucky Medical Center" are "Drug" (117 trials), "Device" (22 trials), "Other" (21 trials), "Biological" (15 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "placebo" (5 trials), "Lamivudine" (3 trials), "Methylphenidate" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Kentucky Medical Center" are 170 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 29 active trials in "University of Kentucky Medical Center". 1 are not yet recruiting, 22 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 103 completed trials in University of Kentucky Medical Center, undefined suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kentucky Medical Center, 20 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 28 trials that are defined as “Not Applicable".